Remission of renal disease: recounting the challenge, acquiring the goal.
Brenner
Barry M
BM
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115-6195, USA. bbrenner@partners.org
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D002986:Clinical Trials as Topic; D003928:Diabetic Nephropathies / Q000188:drug therapy / Q000503:physiopathology; D004032:Diet; D018450:Disease Progression; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000503:physiopathology; D007678:Kidney Glomerulus / Q000378:metabolism; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D012076:Renal Agents / Q000627:therapeutic use*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D012076:Renal Agents